145 related articles for article (PubMed ID: 14744422)
21. Results of the international study of the implantable pacemaker cardioverter-defibrillator. A comparison of epicardial and endocardial lead systems. The Pacemaker-Cardioverter-Defibrillator Investigators.
Zipes DP; Roberts D
Circulation; 1995 Jul; 92(1):59-65. PubMed ID: 7788918
[TBL] [Abstract][Full Text] [Related]
22. [Reticulated teleangiectatic erythema after implantation of medical devices. An increasingly occurring phenomenon?].
Hinterberger L; Müller CS; Vogt T; Pföhler C
Hautarzt; 2011 Oct; 62(10):770-3. PubMed ID: 21437705
[TBL] [Abstract][Full Text] [Related]
23. Contact dermatitis around a tracheostoma due to salbutamol sulfate and Aldecin.
Tsuruta D; Sowa J; Kobayashi H; Ishii M
Contact Dermatitis; 2006 Feb; 54(2):121-2. PubMed ID: 16487287
[TBL] [Abstract][Full Text] [Related]
24. Entirely polytetrafluoroethylene coating for pacemaker system contact dermatitis.
Tamenishi A; Usui A; Oshima H; Ueda Y
Interact Cardiovasc Thorac Surg; 2008 Apr; 7(2):275-7. PubMed ID: 18063607
[TBL] [Abstract][Full Text] [Related]
25. Telangiectatic pacemaker erythema.
Lin YC; Chiu HC; Chu CY; Sun CC
Clin Exp Dermatol; 2003 Jul; 28(4):447-8. PubMed ID: 12823312
[No Abstract] [Full Text] [Related]
26. An unusual skin reaction to an implanted medullar neurostimulator: Reticular telangiectatic erythema.
Sanii S; Menzinger S; Piletta P; Kaya G
Contact Dermatitis; 2023 Sep; 89(3):200-201. PubMed ID: 37285856
[No Abstract] [Full Text] [Related]
27. Prurigo pigmentosa from contact allergy to chrome in detergent.
Kim MH; Choi YW; Choi HY; Myung KB
Contact Dermatitis; 2001 May; 44(5):289-92. PubMed ID: 11298695
[TBL] [Abstract][Full Text] [Related]
28. Subcutaneous implantable cardioverter-defibrillator: First single-center experience with other cardiac implantable electronic devices.
Kuschyk J; Stach K; Tülümen E; Rudic B; Liebe V; Schimpf R; Borggrefe M; Röger S
Heart Rhythm; 2015 Nov; 12(11):2230-8. PubMed ID: 26073595
[TBL] [Abstract][Full Text] [Related]
29. [Two cases of cutaneous erythema following spinal cord stimulation].
Delaplace M; Maître F; Dufour T; Landrieux I; Gauthier P; Jebira P; Estève E
Ann Dermatol Venereol; 2010 Apr; 137(4):297-300. PubMed ID: 20417365
[TBL] [Abstract][Full Text] [Related]
30. Persistent telangiectatic erythema associated with an automatic implantable cardioverter defibrillator.
Krasagakis K; Vogt R; Tebbe B; Goerdt S
Br J Dermatol; 1997 Apr; 136(4):633. PubMed ID: 9155977
[No Abstract] [Full Text] [Related]
31. Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry.
Gadler F; Valzania C; Linde C
Europace; 2015 Jan; 17(1):69-77. PubMed ID: 25336667
[TBL] [Abstract][Full Text] [Related]
32. Multiple shocks after upgrade of an implantable cardioverter-defibrillator to a cardiac resynchronization therapy-defibrillator device.
Francisco GM; Sharma S; Dougherty AH; Kantharia BK
Cardiol J; 2009; 16(5):473-6. PubMed ID: 19753529
[TBL] [Abstract][Full Text] [Related]
33. Pacemaker and implantable cardioverter-defibrillator use in a US myotonic dystrophy type 1 population.
Bhakta D; Shen C; Kron J; Epstein AE; Pascuzzi RM; Groh WJ
J Cardiovasc Electrophysiol; 2011 Dec; 22(12):1369-75. PubMed ID: 22035077
[TBL] [Abstract][Full Text] [Related]
34. Recalls and safety alerts involving pacemakers and implantable cardioverter-defibrillator generators.
Maisel WH; Sweeney MO; Stevenson WG; Ellison KE; Epstein LM
JAMA; 2001 Aug; 286(7):793-9. PubMed ID: 11497532
[TBL] [Abstract][Full Text] [Related]
35. A completely subcutaneous implantable cardioverter defibrillator system functioning simultaneously with an endocardial implantable cardioverter defibrillator programmed as pacemaker.
van Opstal J; Geskes G; Debie L
Europace; 2011 Jan; 13(1):141-2. PubMed ID: 20587539
[TBL] [Abstract][Full Text] [Related]
36. Erythema multiforme-like generalized allergic contact dermatitis caused by Alpinia galanga.
Hong SJ; Chang CH
Contact Dermatitis; 2006 Feb; 54(2):118-20. PubMed ID: 16487286
[TBL] [Abstract][Full Text] [Related]
37. Pacemaker contact sensitivity: clinical recognition and management.
Abdallah HI; Balsara RK; O'Riordan AC
Ann Thorac Surg; 1994 Apr; 57(4):1017-8. PubMed ID: 8166499
[TBL] [Abstract][Full Text] [Related]
38. Inappropriate implantable defibrillator discharge caused by a retained pacemaker lead fragment.
Lickfett L; Wolpert C; Jung W; Spehl S; Pizzulli L; Esmailzadeh B; Lüderitz B
J Interv Card Electrophysiol; 1999 Jul; 3(2):163-7. PubMed ID: 10387144
[TBL] [Abstract][Full Text] [Related]
39. Runaway pacemaker in an implantable cardioverter defibrillator.
Carpenter CM; Galvin J; Guy M; McGovern BA
J Cardiovasc Electrophysiol; 1998 Sep; 9(9):1008-11. PubMed ID: 9786083
[TBL] [Abstract][Full Text] [Related]
40. Telangiectatic reticular erythema unrelated to cardiac devices.
Mercader-García P; Torrijos-Aguilar A; de La Cuadra-Oyanguren J; Vilata-Corell JJ; Fortea-Baixauli JM
Arch Dermatol; 2005 Jan; 141(1):106-7. PubMed ID: 15655161
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
